Skip to main content
SpringerLink
Log in

Growing use of biologicals for immunologic disease in the US

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. BioTrends Research Group Inc.New BioTrends Report Highlights the Growing Use of Biologics among Dermatologists and Rheumatologists in the US. Media Release: 30 Apr 2007. Available from: URL: http://www.bio-trends.com

  2. Decision Resources Inc.Enbrel, Remicade, and Humira Have Dramatically Transformed the Drug Market for the Treatment of Psoriatic Arthritis. Media Release: 30 Apr 2007. Available from: URL: http://www.decisionresources.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Growing use of biologicals for immunologic disease in the US. Pharmacoecon. Outcomes News 528, 10 (2007). https://doi.org/10.2165/00151234-200705280-00025

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705280-00025

Keywords

Search

Navigation